ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline IQV Q1 2026 Earnings EPS Beats Expectations as Stock Gains 22 FCPT Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds TEX Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher Recursion Pharmaceuticals Q1 2026 Earnings EPS Beat Amidst Pipeline Development VNET Q4 2025 Earnings Record EPS Beat on Surprise Profitability